Research Article
Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson’s Disease: Online-Based Delphi Survey
Figure 3
Expert opinions for actions to take in case of dyskinesia and safinamide use. Troublesome dyskinesia (Q5): action taken for troublesome dyskinesia during safinamide use; non-troublesome dyskinesia (Q6): action taken in using safinamide in patients with non-troublesome dyskinesia. 1Nearing consensus of disagreement. 2Nearing consensus of agreement. PD : Parkinson’s disease.